Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease

被引:0
|
作者
Jacob W. Vogel
Yasser Iturria-Medina
Olof T. Strandberg
Ruben Smith
Elizabeth Levitis
Alan C. Evans
Oskar Hansson
机构
[1] McGill University,Montreal Neurological Institute
[2] Lund University,Clinical Memory Research Unit
[3] Skåne University Hospital,Memory Clinic
[4] UC San Francisco,Brigham and Women’s Hospital
[5] UC San Diego,Memory Clinic
[6] Mayo Clinic,Department of Neurology
[7] UC Berkeley,Department of Neurosurgery
[8] U Pennsylvania,Clinical Neurochemistry Laboratory
[9] USC,undefined
[10] UC Davis,undefined
[11] Harvard Medical School,undefined
[12] Indiana University,undefined
[13] Washington University St. Louis,undefined
[14] University of Pennsylvania,undefined
[15] Janssen Alzheimer Immunotherapy,undefined
[16] University of Washington,undefined
[17] University of London,undefined
[18] USC School of Medicine,undefined
[19] UCSF MRI,undefined
[20] University of Michigan,undefined
[21] University of Utah,undefined
[22] Banner Alzheimer’s Institute,undefined
[23] University of Pittsburgh,undefined
[24] UPenn School of Medicine,undefined
[25] UC Irvine,undefined
[26] Khachaturian,undefined
[27] Radebaugh & Associates,undefined
[28] Inc and Alzheimer’s Association’s Ronald and Nancy Reagan’s Research Institute,undefined
[29] General Electric,undefined
[30] Brown University,undefined
[31] National Institute on Aging/National Institutes of Health,undefined
[32] Oregon Health and Science University,undefined
[33] University of Southern California,undefined
[34] University of California San Diego,undefined
[35] Baylor College of Medicine,undefined
[36] Columbia University Medical Center,undefined
[37] Washington University,undefined
[38] University of Alabama Birmingham,undefined
[39] Mount Sinai School of Medicine,undefined
[40] Rush University Medical Center,undefined
[41] Wien Center,undefined
[42] Johns Hopkins University,undefined
[43] New York University,undefined
[44] Duke University Medical Center,undefined
[45] University of Kentucky,undefined
[46] University of Rochester Medical Center,undefined
[47] University of California,undefined
[48] University of Texas Southwestern Medical School,undefined
[49] Emory University,undefined
[50] University of Kansas,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Tau is a hallmark pathology of Alzheimer’s disease, and animal models have suggested that tau spreads from cell to cell through neuronal connections, facilitated by β-amyloid (Aβ). We test this hypothesis in humans using an epidemic spreading model (ESM) to simulate tau spread, and compare these simulations to observed patterns measured using tau-PET in 312 individuals along Alzheimer’s disease continuum. Up to 70% of the variance in the overall spatial pattern of tau can be explained by our model. Surprisingly, the ESM predicts the spatial patterns of tau irrespective of whether brain Aβ is present, but regions with greater Aβ burden show greater tau than predicted by connectivity patterns, suggesting a role of Aβ in accelerating tau spread. Altogether, our results provide evidence in humans that tau spreads through neuronal communication pathways even in normal aging, and that this process is accelerated by the presence of brain Aβ.
引用
收藏
相关论文
共 50 条
  • [21] Lactylation of tau in human Alzheimer's disease brains
    Zhang, Xiaoyu
    Liu, Yan
    Rekowski, Michaella J.
    Wang, Ning
    ALZHEIMERS & DEMENTIA, 2025, 21 (02)
  • [22] Spread of pathological human Tau from neurons to oligodendrocytes and loss of high-firing pyramidal neurons in aging mice
    Viney, Tim J.
    Sarkany, Barbara
    Ozdemir, A. Tugrul
    Hartwich, Katja
    Schweimer, Judith
    Bannerman, David
    Somogyi, Peter
    CELL REPORTS, 2022, 41 (07):
  • [23] Development of inhibitors of pathological tau hyperphosphorylation for a disease modifying approach to Alzheimer's disease
    Sahagun, H
    Hübinger, G
    Klafki, H
    Gordon, S
    Ferrand, S
    Mülbacher, S
    Müller, S
    Seneci, P
    Monse, B
    Fröhner, W
    Casiraghi, L
    Thillaye du Boullay, O
    Braxmeier, T
    LeCorre, S
    Dirscherl, L
    Jolivalt, C
    Lahu, G
    Sobek-Klocke, I
    Plesnila, N
    Hutton, M
    Roder, H
    NEW TRENDS IN ALZHEIMER AND PARKINSON RELATED DISORDERS: ADPD 2005, 2005, : 71 - 76
  • [24] Neuroanatomical spread of amyloid β and tau in Alzheimer's disease: implications for primary prevention
    Insel, Philip S.
    Mormino, Elizabeth C.
    Aisen, Paul S.
    Thompson, Wesley K.
    Donohue, Michael C.
    BRAIN COMMUNICATIONS, 2020, 2 (01)
  • [25] Pathological tau proteins in argyrophilic grain disease
    Simic, G
    LANCET NEUROLOGY, 2002, 1 (05): : 276 - 276
  • [26] In vitro molecular reconstruction of the pathological truncation of tau protein in Alzheimer's disease
    Ovecka, M
    Novak, M
    Cattaneo, A
    CHEMICAL PAPERS, 1998, 52 : 315 - 315
  • [27] Immunotherapy Targeting Pathological Tau Protein in Alzheimer's Disease and Related Tauopathies
    Sigurdsson, Einar M.
    JOURNAL OF ALZHEIMERS DISEASE, 2008, 15 (02) : 157 - 168
  • [28] Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies
    Irwin, David J.
    Cohen, Todd J.
    Grossman, Murray
    Arnold, Steven E.
    Xie, Sharon X.
    Lee, Virginia M. -Y.
    Trojanowski, John Q.
    BRAIN, 2012, 135 : 807 - 818
  • [29] Acetylated Tau, a Novel Pathological Signature in Alzheimer's Disease and Other Tauopathies
    Irwin, David J.
    Cohen, Todd
    Grossman, Murray
    Arnold, Steven E.
    Xie, Sharon X.
    Lee, Virginia M. Y.
    Trojanowski, John Q.
    ANNALS OF NEUROLOGY, 2011, 70 : S89 - S89
  • [30] Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer's disease
    Shim, Kyu Hwan
    Kang, Min Ju
    Youn, Young Chul
    An, Seong Soo A.
    Kim, SangYun
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)